scPharmaceuticals Inc.
SCPH
$4.85
$0.286.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.70% | -4.76% | 46.32% | -105.41% | -21.14% |
| Total Depreciation and Amortization | 1.59% | 3.28% | 481.25% | -130.77% | 1.96% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -- | -- |
| Total Other Non-Cash Items | 57.27% | -19.51% | -80.40% | 435.38% | 381.43% |
| Change in Net Operating Assets | -1,015.18% | -236.59% | 103.80% | 33.26% | -160.46% |
| Cash from Operations | 6.00% | -12.86% | 12.84% | 13.86% | -14.27% |
| Capital Expenditure | -- | -- | -33.33% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Investing | -- | -- | -33.33% | -1,000.00% | -100.00% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -99.68% | 18,837.81% | 56.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.29% | -21.20% | -104.00% | -- | -- |
| Cash from Financing | 35.80% | -54.04% | -100.90% | 24,780.92% | 1,786.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.60% | -14.42% | -129.88% | 365.66% | -271.43% |